News Archive

July 2014

New report by the MiP Consortium on the Contribution of Malaria Control to Maternal and Newborn Health launched at the annual High-Level Segment of the United Nations Economic and Social Council (ECOSOC) in New York on 10 July.
July 2014

November 2013

MiP Consortium members, Prof. Feiko ter Kuile, Dr. Patrick Walker and Dr. Steve Taylor present at 62nd ASTMH meeting, November 2013, Washington DC, USA

November 2013

MiP Consortium CEO, Prof. Feiko ter Kuile, from LSTM, presented during the ASTMH 2013 Conference, in Washington DC, USA, on Thursday 14th November, between 19:00 p.m and 21:00 p.m. The session was entitled: "The state of the art of malaria in pregnancy: Why MiP is a priority for malaria control programs". Location: Marriott Wardman Park Hotel, Ballroom, Salon 3.

MiP Consortium member, Dr. Patrick Walker, from the School of Public Health, Imperial College London, also presented during the ASTMH 2013 Conference, on Thursday 14th November, between 13:45 p.m and 15:30 p.m. The session was entitled: "Estimates of the risk of placental infection and the burden of attributable LBW in Africa in 2010". Location: Marriott Wardman Park Hotel, Virginia Room.

And finally, MiP Consortium member, Dr. Steve Taylor, from Duke University Medical Center, Durham, USA, also presented during the ASTMH 2013 Conference, on Friday 15th November, between 08:15 a.m and 09:45 a.m. The session was entitled: "Genetic lineages of emerging sulfadoxine-resistant P. falciparum in pregnancy-associated malaria in Malawi". Location: Marriott Wardman Park Hotel, Ballroom, Salon 3.

For further details about the 2013 conference please visit the ASTMH website


October 2013

MiPc members present latest results at 3 symposia during 6th MIM Conference in Durban, South Africa

October 2013

The MIM Pan-African Malaria Conference is the largest gathering of the malaria community and therefore provides the ideal opportunity to showcase novel findings, innovations and ground breaking research. Since the first MIM conference in Senegal 1997, the global face of malaria has changed considerably, with malaria elimination now a viable option in many African countries. To highlight this paradigm shift, the 2013 conference is appropriately themed: “Moving towards malaria elimination: Investing in research and control” and included both plenary sessions and symposia dedicated to this topic.

The MiP Consortium coordinated 3 key research symposia entitled:

  1. Increasing access to malaria prevention among pregnant women: Results from systematic reviews and economic and anthropological studies by the MiP Consortium Held on Tuesday 8th October, 11:30 to 13:00 p.m. Chaired by Halidou Tinto and Harry Tagbor;
  2. Insecticide treated nets, intermittent preventive treatment and intermittent screening and treatment for preventing malaria in pregnancy in sub-Saharan Africa: Results from the MiP Consortium. Held on Wednesday 9th October, 08:00 to 09:30 a.m.  Chaired by Meghna Desai and Victor Mwapasa;
  3. Burden and control of Plasmodium flaciparum and Plasmodium vivax malaria in pregnancy in Asia, the Pacific and Latin America: Results from the MiP Consortium Held on Wednesday 9th October, 16:30 to 18:00 p.m. Chaired by Norma Padilla and Rose Leke.

For further details and highlights from the 6th MIM visit their website.

MiP Consortium members and stakeholders attend fifth annual meeting in Durban, South Africa

October 2013


Members and stakeholders from the MiP Consortium recently participated in a 3 day annual meeting held between 3-5 October 2013 in Durban, South Africa. This fifth annual meeting was held at the Oyster Box Hotel in Umhlanga, Durban, ahead of the 6th MIM Pan-African Malaria conference.

Participants reported on latest results from completed study activities, focused on the harmonization of results reporting across major themes and activities and developed concrete plans and deliverables for communicating Consortium research findings for policy to the wider public. For more information on the progress of the Consortium studies visit the project pages of our website here.


July 2013

MiP Consortium Public Health Impact study investigates barriers to interventions for preventing malaria in pregnancy across sub-Saharan Africa

July 2013


Malaria in Pregnancy Consortium Programme Manager Jenny Hill and colleagues at the London School of Hygiene & Tropical Medicine (LSHTM), and PATH in Seattle, USA, have conducted an analysis into the main barriers to the access, delivery and use of interventions that help to prevent malaria in pregnant women across sub-Saharan African countries. Study findings indicate that barriers are relatively consistent across countries and may provide a helpful checklist to identify the factors influencing uptake of these important interventions.

The outcomes of the study published today in the journal PLOS Medicine (click here for full article), also found that there were more barriers to the uptake of intermittent preventative treatment in pregnancy (IPTp) with the drug SP (sulfadoxine-pyrimethamine) than the use of insecticide-treated bed nets (ITNs, which protect pregnant women from the bites of infected mosquitoes). These findings are important as malaria in pregnancy is responsible for the deaths of about 200,000 newborn babies and 10,000 women every year and can also cause miscarriage and preterm delivery yet these simple, inexpensive interventions can prevent malaria.

Interviewed yesterday by Voice of America Science Correspondent Jessica Berman, Jenny Hill commented that “They are very powerful interventions that could go a long way to reducing the burden of malaria and improving the outcomes, both in pregnant women and their infants”. To read the full interview visit their website here.


June 2013

MiP Consortium Secretariat in conversation with International Innovation

June 2013

In the final instalment of a two-part conversation between International Innovation magazine and LSTM, Malaria in Pregnancy Consortium Chief Executive Officer Professor Feiko ter Kuile and Programme Manager Jenny Hill offer an insight into the latest research findings made by the collaboration, as well as the challenges that face clinicians and researchers in controlling malaria among women in endemic regions.

Click here to read the full dissemination document highlighting the work of the Consortium, which is also available online.

February 2013

LSTM study by MiP Consortium members leads WHO to update its malaria prevention policy

February 2013

Members of the MiP Consortium, together with other leading scientisits have published a systematic review and meta-analysis on Intermittent Preventive Therapy for Malaria During Pregnancy Using 2 vs 3 or More Doses of Sulfadoxine-Pyrimethamine and Risk of Low Birth Weight in Africa in the February edition of the Journal of the American Medical Association (JAMA).

The study led by Liverpool School of Tropical Medicine has been a critical element in helping the World Health Organization (WHO) to update its policy recommendation on intermittent preventive treatment for the prevention of malaria in pregnant women (IPTp) who live in malaria-endemic regions of sub-Saharan Africa.

For more information on the article, please view the latest MiPc press release, available online at the MiPc and LSTM websites.


October 2012

MiP Consortium members and stakeholders present at Challenges in Malaria Research Conference in Basel, Switzerland

October 2012

Members and stakeholders from the MiP Consortium will coordinate and act as keynote speakers during the forthcoming 2 day conference to be held between 10-12 October 2012 in Basel, Switzerland. The "Challenges in Malaria Research: Progress Towards Elimination" conference is hosted by the BioMed Central, in conjunction with its journals Malaria Journal and Parasites & Vectors.

Following the success of the inaugural malaria conference in 2010, entitled “Parasite to Prevention: Advances in the understanding of malaria”, this second conference will bring together leading malaria researchers to review current progress and to chart future challenges. Internationally renowned speakers will present their insights into malaria elimination, including social science and policies; Artemisinin resistance; new drugs; vaccines; diagnostic challenges and vector controls.

For more information on the Challenges conference including the latest agenda visit here.


June 2012

MiP Consortium members attend Maternal Health Task Force Technical Meeting in Istanbul, Turkey

June 2012

Senior members of the MiP Consortium will present new data from the Public Health Impact studies during a forthcoming 3 day meeting between 26-28 June 2012 in Istanbul, Turkey. The meeting "Malaria in Pregnancy: A Solvable Problem—Bringing the Maternal Health and Malaria Communities Together", is coordinated by the Maternal Health Task Force, (MHTF) and hopes to provide a neutral platform for dialogue, partnership building, and exploring ideas for increasing coverage of interventions to address malaria in pregnancy in sub-Saharan Africa.

Supported by the Bill and Melinda Gates Foundation, PATH, London School of Hygiene and Tropical Medicine aswell as LSTM, the MHTF aims to contribute to shaping collective efforts to improve maternal health worldwide, serving as a catalyst to address one of the most neglected areas in global health and development. For more information on the Task Force Technical Meeting in Istanbul and their active blog on malaria in pregnancy visit here.


May 2012

New clinician joins crucial MiP Consortium IPTp study in Papua New Guinea

May 2012

Dr. Holger Unger originally from Scotland recently joined the Papua New Guinea Institute of Medical Research (IMR), Port Moresby, PNG as project clinician working with the IPTp team on “Intermittent preventive treatment with azithromycin-containing regimens for the prevention of malarial infections and anaemia and the control of sexually transmitted infections in pregnant women in Papua New Guinea”.

The IPTp study began recruiting women late in 2009, with the aim of enrolling almost 3000 women across seven sites around Madang, PNG in their second trimester of pregnancy. These women are followed until delivery and their babies until their first birthday.

The committed team also work closely on a number of collaborative malaria in pregnancy sub-studies with the University of Melbourne, Australia including: understanding the use of combined treatment of malaria and sexually transmitted infections (STIs), betelnut chewing and pregnancy, and maternal malaria prevention and early childhood illnesses.

A recent media article about the studies has been published by the IMR in their quarterly newsletter. For details see here.

MiP Consortium PREGACT initiative undertakes pioneering research into the safety and efficacy of new combination ACT’s

May 2012

Coordinated by Prof. Umberto D’Alessandro at the Institute of Tropical Medicine, Antwerp, the PREGACT study “Safe and efficacious artemisinin-based combination treatments for African pregnant women with malaria” aims to study the effects of newly-available artemisinin-based combination treatments on P.faciparum infected pregnant women and to collect explanatory variables for treatment failure and recurrent parasitaemia.

The PREGACT study began recruiting women in the second and third trimester of pregnancy across 4 treatment centres in Burkina Faso, Ghana, Malawi and Zambia in 2010, with the aim of enrolling 3840 women by the end of 2012.

A dissemination document highlighting the study has been published by the online journal International Innovation. For details see here.

MiP Consortium Multicentre Mefloquine treatment study concludes recruitment
March 2012


The MiP Consortium is pleased to announce the completion of recruitment for the multi-centre study “Evaluation of alternative antimalarial drugs to sulfadoxine-pyrimethamine for intermittent preventive treatment in pregnancy (IPTp) in the context of insecticide treated nets” coordinated by Prof. Clara Menendez, of the Barcelona Centre for International Health Research (CRESIB, Hospital Clínic-Universitat de Barcelona), Barcelona, Spain and Dr. Meghna Desai, from Kenya Medical Research Institute/ Centers for Disease Control and Prevention, (Kemri CDC), Kisumu, Kenya.

The study, conducted in 5 African countries: Mozambique, Benin, Gabon, Tanzania and Kenya, aims to evaluate the safety, tolerability and efficacy of an alternative drug for preventive treatment of malaria in pregnancy. Up to the end of January 2012, the study has recruited 4,734 pregnant women.

A press release from study co-funders EDCTP can be downloaded here. For further details about the study visit the MiP Consortium project page or read the EDCTP project profile here.


November 2011

MiP Consortium Safety Working Group to present at ASTMH 2011 Conference, Philadelphia
December 2011

Members of the MiP Consortium Safety Working Group, Esperanca Sevene and Cheryl Pace, will present safety data as part of the ACT Consortium symposium during the forthcoming ASTMH 2011 Conference, Philadelphia, on 5th December 2011, between 10:15 a.m – 12:15 p.m., location: Philadelphia Marriott Downtown Hotel, Grand Ballroom Salon G

For further details about the ASTMH conference please visit the ASTMH website here


3 - 6 October, 2011

ECTMIH Barcelona 3 - 6 October 2011

Malaria in Pregnancy Consortium symposium at the 7th European Congress on Tropical Medicine and International Health, ECTMIH, Barcelona

The Malaria in Pregnancy Consortium to host a MiP symposium at the 7th European Congress on Tropical Medicine and International Health, ECTMIH, Barcelona, 3 - 6 October, 2011. Further details of the symposium will be posted on the Congress website in due course


1-3 June 2011

4th MiPc AGM Maputo, Mozambique, 1-3 June 2011

Malaria in Pregnancy Consortium Annual meeting, Maputo

The MiP Consortium recently held their fourth annual meeting at the Cardoso Hotel, Maputo, Mozambique between 1-3 June 2011 co-funded by the Bill and Melinda Gates Foundation and EDCTP. The three day meeting was hosted by Dr. Eusebio Macete, Director of the Centro de Investigação em Saúde de Manhiça (CISM) ( and was officially opened by the Mozambican Deputy Minister of Health, Dr. Nazira Vali, who stressed the continuing importance of tackling malaria in pregnancy.


Jan 2011

Smiling kids

EDCTP receives renewed funding

Following the positive evaluation and impact assessment of the EDCTP programme, participating member states, African representatives and the EC agreed to continue with EDCTP. The EDCTP-II programme will build on the current programme and will be bigger and more ambitious, covering a period of up to twelve years.